Home Newsfeeds Jefferies Upgrades Check Point Software to Buy, Raises Price Target to $150

Jefferies Upgrades Check Point Software to Buy, Raises Price Target to $150

Jefferies analyst Joseph Gallo upgrades Check Point Software (NASDAQ:CHKP) from Hold to Buy and raises the price target from $135 to $150.

byBenzinga Newsdesk

January 5, 2023

1 minute read

Jefferies analyst Joseph Gallo upgrades Check Point Software (NASDAQ:CHKP) from Hold to Buy and raises the price target from $135 to $150.

BILL Announces Repurchase ~ $234.5M Of Additional 0.0% Convertible Senior Notes Due 2025

By Benzinga Newsdesk

May 30, 8:15 AM

BILL (NYSE:BILL), a leading financial operations platform for small and midsize businesses (SMBs), today announced that it has entered into various privately negotiated repurchase transactions (collectively, the

BILL

Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End

By Vandana Singh

July 24, 11:10 AM

Syndax Pharmaceuticals (NASDAQ: SNDX) and Incyte Corporation (NASDAQ: INCY) announced topline data from the AGAVE-201 trial of axatilimab, in adult and pediatric patients with chronic graft-versus-host di

INCY